Aug. 12, 2013
/PRNewswire/ -- Today Grifols was honored at the California State Legislature by state Senator Kevin de Leon (D-
) and Assembly Member Jimmy Gomez (D-
East Los Angeles
) marking the 10
Anniversary of the Company's establishment of its U.S. headquarters in
, and a decade of conducting business in
and improving the health and well-being of people around the world.
Grifols, a global healthcare company based in
, produces life-saving plasma medicines out of human plasma for people with rare, chronic and life-threatening conditions.
is one of Grifols' largest and most important business hubs with
housing the company's U.S. headquarters and its 350,000 square-foot state-of-the-art manufacturing facility. Grifols acquired the El Sereno facility in
East Los Angeles
in 2003. Since then, it has completed a large scale
$135 million dollar
capital investment project that includes the construction of a new 95,000 square foot, intravenous immune globulin (IVIG) production facility.
"Grifols is proud of the Company's significant investments in the state, reflecting our strong commitment to
and to meeting the needs patients who rely on life-saving plasma therapies well into the future," commented
, CEO of Grifols Inc.
"Grifols is pleased to employ over 1,200 Californians in high-quality skilled jobs and continues to foster a thriving workforce in
and across the state," said
, President of Grifols Biologicals Inc., who has also developed strong partnerships with
Los Angeles Trade Technical College
California State University, Los Angeles
, and the Wilshire-Metro WorkSource Center to promote education, job training and skills development for area residents.
In addition to the
site, Grifols operates a 140,000 square-foot climate-controlled plasma warehouse and final packaging center in the City of Industry and owns and operates six plasma donation centers from
, where Californians donate their plasma for the production of life-saving medicines.